Creative Biolabs has a professional research team dedicated to the research and development of drug discovery and engineering. Through the team's relentless exploration, the company provides the entire one-stop Protein Degraders-based drug development services from early discovery to pre-clinical evaluation and clinical trials.

As international cooperation with offices around the world, we have an excellent research team, and currently top biotech, contributing to the development of new drugs. With the unremitting efforts of the research team in pursuit of perfection, we have made great progress in the field of proteolysis targeting chimeric molecule (Protein Degraders) and are in a leading position in the international field. Our services consist of different modules that cover every aspect of Protein Degraders development, from ligand identification to biological evaluation. To achieve the best efficacy, we do recommend our one-stop service package that delivers unrivaled value and will take care of your research project from scratch to full development.

Distributed under CC0, from Wiki, without modification.

Traditional drug research and development mainly focuses on directly regulating the activity of proteins or enzymes to treat diseases. Protein Degraders is a technology invented in 2001, which utilizes the "cleaner" in the cell - the ubiquitin-proteasome system. Protein Degraders uses the cell's own protein destruction mechanism to remove specific oncogenic proteins from cells, an alternative to targeted therapy. With our integrated global resources in all aspects, our one-stop Protein Degraders development services will provide you with a platform that could exponentially speed up the process of Protein Degraders development, from ligand identification to chemical integration, and biological evaluation for the cause of a better tomorrow.